Bolt Biotherapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-104.9M | $5.5M |
| FY2021 | — | $250.1M | $27.4M |
| FY2022 | — | $171.5M | $9.2M |
| FY2023 | — | $112.7M | $10.8M |
| FY2024 | — | $57.2M | $7.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $-104.9M | $5.5M |
| FY2021 | — | $250.1M | $27.4M |
| FY2022 | — | $171.5M | $9.2M |
| FY2023 | — | $112.7M | $10.8M |
| FY2024 | — | $57.2M | $7.2M |